Miriam Mengoni
6PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 07, 2025
Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy.Katharina Schumann, Kai Christian Klespe, Cornelia Mauch
|Oct 03, 2024
Pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicenter retrospective data analysis with 70 patients.Inga Hansen-Abeck, Glenn Geidel, Finn Abeck
|Jun 10, 2024
Comprehensive analysis of body composition features in melanoma patients treated with tyrosine kinase inhibitors.Miriam Mengoni, Andreas Dominik Braun, Mattes Simon Hinnerichs
|May 25, 2024
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade.Miriam Mengoni, Andreas Dominik Braun, Mattes Simon Hinnerichs
|Feb 15, 2024
Transactivation of Met signaling by oncogenic Gnaq drives the evolution of melanoma in Hgf-Cdk4 mice.Miriam Mengoni, Andreas Dominik Braun, Sahithi Seedarala
|Aug 14, 2020
The aryl hydrocarbon receptor promotes inflammation-induced dedifferentiation and systemic metastatic spread of melanoma cells.Miriam Mengoni, Andreas Dominik Braun, Evelyn Gaffal
Pageof 1
Frequent Collaborators
5 joint publications
Andreas Dominik Braun
4 joint publications
Thomas Tüting
2 joint publications
Evelyn Gaffal
2 joint publications
Alexey Surov
1 joint publications
Denny Schanze
1 joint publications
Martin Zenker
1 joint publications
Mattes Simon Hinnerichs
1 joint publications
Glenn Geidel
1 joint publications
Finn Abeck
1 joint publications
Julian Kött
